PAYS News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

PA

Mkt Cap

$880.8M

Volume

1.02M

Next Earnings

November 9th

Chart Financials Earnings News About Insider Filings

Why Paysign Plunged TodayPaysign stock dropped 12.3% despite beating Q1 earnings expectations with 50.8% revenue growth and 80% EPS growth. The decline was triggered by management's decision to maintain prior guidance rather than raise it, disappointing investors after the stock had already rallied 35% year-to-date. At 23.5x forward earnings with nearly 100% projected earnings growth, analysts suggest the stock may be attractive at current levels, though small-cap risks remain.The Motley Fool · May 13, 2026

Paysign's Patient Affordability Drives 51% Revenue Growth and Significant Margin Expansion for First Quarter 2026Paysign (NASDAQ: PAYS) reported strong Q1 2026 results with 51% revenue growth to $28.04 million, driven by 82% pharma revenue growth and 25% plasma revenue growth. Net income nearly doubled to $5.44 million ($0.09 per share), with adjusted EBITDA up 113% to $10.59 million. The company added 45 net patient affordability programs (135 total) and 89 plasma centers (573 total), exceeding guidance across all metrics.Benzinga · May 12, 2026

Why Paysign Stock Is Skyrocketing TodayPaysign stock surged 35.8% on March 25, 2026, following strong Q4 earnings that beat sales expectations at $22.76M versus $21.55M forecast. The company projects 2026 revenue between $106.5M-$110.5M (32.5% growth) with net income of $13M-$16M, driven by momentum in pharmaceuticals and plasma verticals. Despite today's rally, the stock remains down roughly 1% year-to-date.The Motley Fool · Mar 25, 2026

2 Little-Known Stocks on My Watch List Right NowMotley Fool analysts discuss two lesser-known stocks that could become much larger businesses in the future, offering opportunities beyond popular household names for investors willing to look beyond mainstream investments.The Motley Fool · Jan 27, 2026

Paysign (PAYS) Q2 Revenue Jumps 33%Paysign reported strong Q2 2025 earnings with 33.1% revenue growth, driven by robust pharma patient affordability programs, despite softening plasma revenue. The company raised its full-year guidance and showed significant profitability improvements.The Motley Fool · Aug 6, 2025

A Glimpse Into The Expert Outlook On PaySign Through 7 AnalystsPaySign (NASDAQ:PAYS) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 4 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 2 3 0 0 0 3M Ago 1 0 0 0 0 Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $6.07, along with a high estimate of $7.00 and a low estimate of $4.50. This current average has increased by 8.98% from the previous average price target of $5.57. Understanding Analyst Ratings: A Comprehensive Breakdown The analysis of recent analyst actions sheds light on the perception of PaySign by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Gary Prestopino Barrington Research Maintains Outperform $7.00 $7.00 Gary Prestopino Barrington Research Maintains Outperform $7.00 $7.00 Gary Prestopino Barrington Research Raises Outperform $7.00 $5.50 Michael Diana Maxim Group Raises Buy $6.00 $5.50 Gary Prestopino Barrington Research Maintains Outperform $5.50 $5.50 Peter Heckmann DA Davidson Raises Buy $5.50 $4.50 Peter Heckmann DA Davidson Raises Buy $4.50 $4.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to ...Full story available on Benzinga.comBenzinga · Jun 28, 2024

Evaluating PaySign: Insights From 9 Financial AnalystsIn the last three months, 9 analysts have published ratings on PaySign (NASDAQ:PAYS), offering a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 5 0 0 0 Last 30D 0 1 0 0 0 1M Ago 2 2 0 0 0 2M Ago 1 0 0 0 0 3M Ago 1 2 0 0 0 Analysts have set 12-month price targets for PaySign, revealing an average target of $5.61, a high estimate of $7.00, and a low estimate of $4.00. This current average reflects an increase of 10.87% from the previous average price target of $5.06. Interpreting Analyst Ratings: A Closer Look An in-depth analysis of recent analyst actions unveils how financial experts perceive PaySign. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Gary Prestopino Barrington Research Maintains Outperform $7.00 $7.00 Gary Prestopino Barrington Research Raises Outperform $7.00 $5.50 Michael Diana Maxim Group Raises Buy $6.00 $5.50 Gary Prestopino Barrington Research Maintains Outperform $5.50 $5.50 Peter Heckmann DA Davidson Raises Buy $5.50 $4.50 Peter Heckmann DA Davidson Raises Buy $4.50 $4.00 Gary Prestopino Barrington Research Maintains Outperform $5.50 $5.50 Peter Heckmann DA Davidson Raises Buy $4.00 $3.00 Gary Prestopino Barrington Research Maintains Outperform $5.50 - Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ...Full story available on Benzinga.comBenzinga · May 28, 2024

Breaking Down PaySign: 5 Analysts Share Their ViewsIn the preceding three months, 5 analysts have released ratings for PaySign (NASDAQ:PAYS), presenting a wide array of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 1 2 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $5.0, a high estimate of $5.50, and a low estimate of $4.00. This current average has increased by 17.65% from the previous average price target of $4.25. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive PaySign is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Peter Heckmann DA Davidson Raises Buy $5.50 $4.50 Peter Heckmann DA Davidson Raises Buy $4.50 $4.00 Gary Prestopino Barrington Research Maintains Outperform $5.50 $5.50 Peter Heckmann DA Davidson Raises Buy $4.00 $3.00 Gary Prestopino Barrington Research Maintains Outperform $5.50 - Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' ...Full story available on Benzinga.comBenzinga · Apr 30, 2024

Gold Moves Higher; Velo3D Shares PlummetU.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The Dow traded up 0.78% to 39,589.55 while the NASDAQ fell 0.02% to 16,312.74. The S&P 500 also rose, gaining, 0.36% to 5,222.18. Check This Out: Top 3 Energy Stocks That May Keep You Up At Night In Q1 Leading and Lagging Sectors Utilities shares jumped by 2% on Wednesday. In trading on Wednesday, communication services shares fell by 0.5%. Top Headline Cintas Corporation (NASDAQ: CTAS) reported better-than-expected third-quarter financial results and raised FY24 guidance. Cintas posted GAAP earnings of $3.84 per share, beating market estimates of $3.59 per share. The company’s quarterly sales came in at $2.406 billion, versus expectations of $2.386 billion, according to data from Benzinga Pro. Cintas increased FY24 annual revenue expectations from $9.48 billion-$9.56 billion to $9.57 billion-$9.60 billion (estimate: $9.56 billion). The firm raised EPS outlook from $14.35-$14.65 to $14.80-$15.00 (estimate: $14.60). Equities Trading UP Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares shot up 44% to $3.2571 after the company announced the publication of pre-clinical data on its lead clinical ...Benzinga · Mar 27, 2024

Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. LuxUrban said it expects preliminary revenue of $28.2 million for the fourth quarter, versus market estimates of $34.199 million, according to data from Benzinga Pro. LuxUrban Hotels shares dipped 27.4% to $1.5523 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers MariaDB plc (NYSE: MRDB) climbed 70.4% to $0.3850 after Progress Software announced that it is possibly considering an offer for the company. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares jumped 68.6% to $3.8099 after the company announced the publication of pre-clinical data on its lead clinical compound, LB-100. Nutriband Inc. (NASDAQ: NTRB) gained 33.2% to $3.9950 after the company provided a clinical and regulatory path overview for its AVERSA Fentanyl patch. Verb Technology Company, Inc. (NASDAQ: VERB) surged 30.5% to $0.3656 after the company announced that its MARKET.live entered into a formal partnership with TikTok to become a service provider for TikTok Shop and will receive a TikTok Shop Partner designation. PaySign, Inc. (NASDAQ: PAYS) gained 28.2% to $4.3299 after the company announced better-than-expected fourth-quarter results. Destiny Tech100 Inc (NASDAQ: DXYZ) rose 26.6% to $11.39 after gaining 9% on Tuesday. PAVmed Inc. (NASDAQ: PAVM) gained 19.7% to $2.4798 after the company issued business update and fourth quarter financial results. Noah Holdings Limited (NYSE: NOAH) rose 17.5% to $11.89 after the company reported fourth quarter financial results. NuScale Power Corporation (NYSE: SMR) rose 17.5% to $4.89. The ONE Group Hospitality, Inc. (NASDAQ: STKS) shares rose 17.2% to $4.70 after the company announced that it will ...Benzinga · Mar 27, 2024

PA

PAYSPaysign, Inc. Common Stock

PAYS

Pay with—

Available Balance0.00

Your PositionYou don't own any PAYS yet.

Related Tickers

Earnings